Des Atouts Changement Date
Adidas EUR 21.45B 383M 2026-09
Adyen EUR 14.72B 2.47B 2026-06
Akzo Nobel EUR 16.02B 114M 2026-09
Alcon AG USD 31.37B 270M 2026-09
Amadeus IT EUR 11.79B 30.7M 2026-09
Amarin USD 634.08M 9.72M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
BASF EUR 79.94B 3.92B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Beiersdorf EUR 13.32B 560M 2026-06
Covestro EUR 13.88B 408M 2026-06
Danone EUR 48.62B 3.55B 2026-06
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.45B 155.97M 2026-09
Genmab DKK 12.52B 139M 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Henkel EUR 36.5B 3.96B 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Infineon EUR 33.45B 1.79B 2026-09
Lakefront Biotherapeutics EUR 3.29B 56.62M 2026-09
Linde USD 88.08B 1.76B 2026-09
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.66B 975M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Philips EUR 28.03B 1.33B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
UCB EUR 18.16B 971M 2025-12